Abstract
Methamphetamine (METH) addiction is a major public health problem in some countries. There is evidence to suggest that METH use is associated with increased risk of developing cardiovascular problems. Here, we investigated the effects of chronic METH administration and withdrawal on the activation of the brain stress system and cardiac sympathetic pathways. Mice were treated with METH (2 mg/kg, i.p.) for 10 days and left to spontaneous withdraw for 7 days. The number of corticotrophin-releasing factor (CRF), c-Fos, and CRF/c-Fos neurons was measured by immunohistochemistry in the paraventricular nucleus of the hypothalamus (PVN) and the oval region of the bed nucleus of stria terminalis (ovBNST), two regions associated with cardiac sympathetic control. In parallel, levels of catechol-o-methyl-transferase (COMT), tyrosine hydroxylase (TH), and heat shock protein 27 (Hsp27) were measured in the heart. In the brain, chronic-METH treatment enhanced the number of c-Fos neurons and the CRF neurons with c-Fos signal (CRF+/c-Fos+) in PVN and ovBNST. METH withdrawal increased the number of CRF+ neurons. In the heart, METH administration induced an increase in soluble (S)-COMT and membrane-bound (MB)-COMT without changes in phospho (p)-TH, Hsp27, or pHsp27. Similarly, METH withdrawal increased the expression of S- and MB-COMT. In contrast to chronic treatment, METH withdrawal enhanced levels of (p)TH and (p)Hsp27 in the heart. Overall, our results demonstrate that chronic METH administration and withdrawal activate the brain CRF systems associated with the heart sympathetic control and point towards a METH withdrawal induced activation of sympathetic pathways in the heart. Our findings provide further insight in the mechanism underlining the cardiovascular risk associated with METH use and proposes targets for its treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abekawa T, Ohmori T, Koyama T (1994) Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens. Brain Res 643(1–2):276–281. https://doi.org/10.1016/0006-8993(94)90033-7
Ammon-Treiber S, Grecksch G, Stumm R, Riechert U, Tischmeyer H, Reichenauer A, Höllt V (2004) Rapid, transient, and dose-dependent expression of hsp70 messenger RNA in the rat brain after morphine treatment. Cell Stress Chaperones 9(2):182–197. https://doi.org/10.1379/CSC-42.1
Beuten J, Payne TJ, Ma JZ, Li MD (2005) Significant association of catechol-O-methyl transferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations. Neuropsychopharmacology 31:675–684
Chu CP, Qiu DL, Kato K, Kunitake T, Watanabe S, Yu NS, Nakazato M, Kannan H (2004) Central stresscopin modulates cardiovascular function through the adrenal medulla in conscious rats. Regul Pept 119(1-2):53–59. https://doi.org/10.1016/j.regpep.2003.12.007
Ciccarone D (2011) Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy. Primary care 38(1):41–58, v-vi. https://doi.org/10.1016/j.pop.2010.11.004
Cubells JF, Rayport S, Rajendran G, Sulzer D (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J Neurosci 14(4):2260–2271
Daniel SE, Rainnie DG (2016) Stress modulation of opposing circuits in the bed nucleus of the stria terminalis. Neuropsychopharmacology 41(1):103–125
Deng X, Feng X, Li S, Gao Y, Yu B, Li G (2015) Influence of the hypothalamic paraventricular nucleus (PVN) on heart rate variability (HRV) in rat hearts via electronic lesion. Biomed Mater Eng 26(Suppl 1):S487–S495. https://doi.org/10.3233/BME-151338
Dettmeyer R, Friedrich K, Schmidt P, Madea B (2009) Heroin-associated myocardial damages—conventional and immunohistochemical investigations. Forensic Sci Int 187(1–3):42–46. https://doi.org/10.1016/j.forsciint.2009.02.014
Dietrich JB, Arpin-Bott MP, Kao D, Dirrig-Grosch S, Aunis D, Zwiller J (2007) Cocaine induces the expression of homer 1b/c, homer 3a/b, and hsp 27 proteins in rat cerebellum. Synapse 61(8):587–594. https://doi.org/10.1002/syn.20412
Dunkley PR, Bobrovskaya L, Graham ME, von Nagy-Felsobuki EI, Dickson PW (2004) Tyrosine hydroxylase phosphorylation: regulation and consequences. J Neurochem 91(5):1025–1043. https://doi.org/10.1111/j.1471-4159.2004.02797.x
Ersche KD, Roiser JP, Lucas M, Domenici E, Robbins TW, Bullmore ET (2011) Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment. Psychopharmacology 214(4):779–789. https://doi.org/10.1007/s00213-010-2087-1
Francesconi W, Berton F, Repunte-Canonigo V, Hagihara K, Thurbon D, Lekic D, Specio SE, Greenwell TN, Chen SA, Rice KC, Richardson HN, O’Dell LE, Zorrilla EP, Morales M, Koob GF, Sanna PP (2009) Protracted withdrawal from alcohol and drugs of abuse impairs long-term potentiation of intrinsic excitability in the juxtacapsular bed nucleus of the stria terminalis. J Neurosci 29(17):5389–5401. https://doi.org/10.1523/JNEUROSCI.5129-08.2009
Garcia-Carmona JA, Milanes MV, Laorden ML (2013) Brain stress system response after morphine-conditioned place preference. Int J Neuropsychopharmacol 16(9):1999–2011. https://doi.org/10.1017/S1461145713000588
Garcia-Carmona JA, Martinez-Laorden E, Milanes MV, Laorden ML (2015) Sympathetic activity induced by naloxone-precipitated morphine withdrawal is blocked in genetically engineered mice lacking functional CRF1 receptor. Toxicol Appl Pharmacol 283(1):42–49. https://doi.org/10.1016/j.taap.2015.01.002
Georgiou P, Zanos P, Ehteramyan M, Hourani S, Kitchen I, Maldonado R, Bailey A (2015) Differential regulation of mGlu5 R and MuOPr by priming- and cue-induced reinstatement of cocaine-seeking behaviour in mice. Addict Biol 20(5):902–912. https://doi.org/10.1111/adb.12208
Georgiou P, Zanos P, Garcia-Carmona JA, Hourani S, Kitchen I, Laorden ML, Bailey A (2016) Methamphetamine abstinence induces changes in u-opioid receptor, oxytocin and CRF systems: association with an anxiogenic phenotype. Neuropharmacology 105:520–532. https://doi.org/10.1016/j.neuropharm.2016.02.012
Gonzales R, Mooney L, Rawson RA (2010) The methamphetamine problem in the United States. Ann Rev Pub Health 31(1):385–398. https://doi.org/10.1146/annurev.publhealth.012809.103600
Henry BL, Minassian A, Perry W (2012) Effect of methamphetamine dependence on heart rate variability. Addict Biol 17(3):648–658. https://doi.org/10.1111/j.1369-1600.2010.00270.x
Ito H, Yeo KK, Wijetunga M, Seto TB, Tay K, Schatz IJ (2009) A comparison of echocardiographic findings in young adults with cardiomyopathy: with and without a history of methamphetamine abuse. Clin Cardiol 32:18–22
Kasch S (1987) Serum catecholamines in cocaine intoxicated patients with cardiac symptoms. Ann Emerg Med 16:481
Kaye S, McKetin R, Duflou J, Darke S (2007) Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction 102(8):1204–1211. https://doi.org/10.1111/j.1360-0443.2007.01874.x
Kazakova TB, Barabanova SV, Novikova NS, Nosov MA, Rogers VV, Korneva EA (2000) Induction of c-fos and interleukin-2 genes expression in the central nervous system following stressor stimuli. Pathophysiology 7(1):53–61. https://doi.org/10.1016/S0928-4680(00)00029-8
Koob GF (2010) The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res 1314:3–14. https://doi.org/10.1016/j.brainres.2009.11.008
Koob GF, Le Moal M (2008) Neurobiological mechanisms for opponent motivational processes in addiction. Philos Trans R Soc Lond Ser B Biol Sci 363(1507):3113–3123. https://doi.org/10.1098/rstb.2008.0094
Koob GF, Volkow ND (2016) Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 3(8):760–773. https://doi.org/10.1016/S2215-0366(16)00104-8
Krasnova IN, Cadet JL (2009) Methamphetamine toxicity and messengers of death. Brain Res Rev 60(2):379–407. https://doi.org/10.1016/j.brainresrev.2009.03.002
Latchman DS (2002) Protection of neuronal and cardiac cells by HSP27. Prog Mol Subcell Biol 28:253–265. https://doi.org/10.1007/978-3-642-56348-5_14
LaVoie MJ, Hastings TG (1999) Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J Neurosci 19(4):1484–1491
Li T, Chen CK, Hu X, Ball D, Lin SK, Chen W et al (2004) Association analysis of the DRD4 and COMT genes in methamphetamine abuse. Am J Med Genet B Neuropsychiatr Genet 129B(1):120–124. https://doi.org/10.1002/ajmg.b.30024
Loogrip ML, Koob GF, Zorrilla EP (2011) Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention. CNS Drugs 25(4):271–287. https://doi.org/10.2165/11587790-000000000-00000
Martínez-Laoden E, Hurle MA, Milanés MV, Laorden ML, Almela P (2012) Morphine withdrawal activates hypothalamic–pituitary–adrenal axis and heat shock protein 27 in the left ventricle: the role of extracellular signal regulated kinase. J Pharmacol Exp Ther 342(3):665–675. https://doi.org/10.1124/jpet.112.193581
Martinez-Laorden E, Garcia-Carmona JA, Baroja-Mazo A, Romecin P, Atucha NM, Milanes MV, Laorden ML (2014) Corticotropin-releasing factor (CRF) receptor-1 is involved in cardiac noradrenergic activity observed during naloxone-precipitated morphine withdrawal. Br J Pharmacol 171(3):688–700. https://doi.org/10.1111/bph.12511
Mehlen P, Mehlen A, Godet J, Arrigo AP (1997) Hsp27 as a switch between differentiation and apoptosis in murine embryonic stem cells. J Biol Chem 272(50):31657–31665. https://doi.org/10.1074/jbc.272.50.31657
Motbey CP, Hunt GE, Bowen MT, Artiss S, McGregor IS (2012) Mephedrone (4-methylmethcathinone, ‘meow’): acute behavioural effects and distribution of Fos expression in adolescent rats. Addict Biol 17(2):409–422. https://doi.org/10.1111/j.1369-1600.2011.00384.x
Mymrikov EV, Seit-Nebi AS, Gusev NB (2011) Large potentials of small heat shock proteins. Physiol Rev 91(4):1123–1159. https://doi.org/10.1152/physrev.00023.2010
Nash JF, Yamamoto BK (1992) Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res 581(2):237–243. https://doi.org/10.1016/0006-8993(92)90713-J
Nijsen MJ, Croiset G, Stam R, Bruinjnzeel A, Diamant M, de Wied D et al (2000) The role of the CRH type 1 receptor in autonomic responses to corticotropin-releasing hormone in the rat. Neurophsychopharmacology 22(4):388–399. https://doi.org/10.1016/S0893-133X(99)00126-8
Nijsen MJ, Croiset G, Diamant M, De Wied D, Wiegant VM (2001) CRH signalling in the bed nucleus of the stria terminalis is involved in stress-induced cardiac vagal activation in conscious rats. Neuropsychopharmacology 24(1):1–10. https://doi.org/10.1016/S0893-133X(00)00167-6
Nobis WP, Kash TL, Silberman Y, Winder DG (2011) β-Adrenergic receptors enhance excitatory transmission in the bed nucleus of the stria terminalis through a corticotrophin-releasing factor receptor-dependent and cocaine-regulated mechanism. Biol Psychiatry 69(11):1083–1090. https://doi.org/10.1016/j.biopsych.2010.12.030
Nuñez C, Martín F, Földes A, Laorden ML, Kovács KJ, Milanés MV (2010) Induction of FosB/ΔFosB in the brain stress system-related structures during morphine dependence and withdrawal. J Neurochem 114(2):475–487. https://doi.org/10.1111/j.1471-4159.2010.06765.x
O’Dell SJ, Weihmuller FB, Marshall JF (1991) Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res 564(2):256–260. https://doi.org/10.1016/0006-8993(91)91461-9
Olive MF, Koenig HN, Nannini MA, Hodge CW (2002) Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol Biochem Behav 72(1-2):213–220. https://doi.org/10.1016/S0091-3057(01)00748-1
Oliveira LA, Almeida J, Benini R, Crestani CC (2015) CRF1 and CRF2 receptors in the bed nucleus of the stria terminalis modulate the cardiovascular responses to acute restraint stress in rats. Pharmacol Res 95-96:53–62. https://doi.org/10.1016/j.phrs.2015.03.012
Ongur D, An X, Price JL (1998) Prefrontal cortical projections to the hypothalamus in macaque monkeys. J Comp Neurol 401(4):480–505. https://doi.org/10.1002/(SICI)1096-9861(19981130)401:4<480::AID-CNE4>3.0.CO;2-F
Panenka WJ, Procyshyn RM, Lecomte T, MacEwan GW, Flynn SW, Honer WG, Barr AM (2013) Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings. Drug Alcohol Depend 129(3):167–179. https://doi.org/10.1016/j.drugalcdep.2012.11.016
Peart JN, Gross GJ (2006) Cardioprotective effects of acute and chronic opioid treatment are mediated via different signaling pathways. Am J Physiol Heart CircPhysiol 291:1746–1753
Risold PY, Swanson LW (1997) Connections of the rat lateral septal complex. Brain Res Rev 24(2-3):115–195. https://doi.org/10.1016/S0165-0173(97)00009-X
Robinson AA, Dunn MJ, McCormack A, dos Remedios C, Rose ML (2010) Protective effect of phosphorylated Hsp27 in coronary arteries through actin stabilization. J Mol Cell Cardiol 49(3):370–379. https://doi.org/10.1016/j.yjmcc.2010.06.004
Rogalla T, Ehrnsperger M, Preville X, Kotlyarov A, Lutsch G, Ducasse C, Paul C, Wieske M, Arrigo AP, Buchner J, Gaestel M (1999) Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation. J BiolChem 274:18947–18956
Sawchenko PE, Swanson LW (1982) Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat. J Comp Neurol 205(3):260–272. https://doi.org/10.1002/cne.902050306
Sharko AC, Kaigler KF, Fadel JR, Wilson MA (2016) Ethanol-induced anxiolysis and neuronal activation in the amygdala and bed nucleus of the stria terminalis. Alcohol 50:19–25. https://doi.org/10.1016/j.alcohol.2015.11.001
Stamatakis AM, Sparta DR, Jennings JH, McElligott ZA, Decot H, Stuber GD (2014) Amygdala and bed nucleus of the stria terminalis circuitry: implications for addiction-related behaviors. Neuropharmacology 76:320–328. https://doi.org/10.1016/j.neuropharm.2013.05.046
Stephans SE, Yamamoto BK (1994) Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse 17(3):203–209. https://doi.org/10.1002/syn.890170310
Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75(6):406–433. https://doi.org/10.1016/j.pneurobio.2005.04.003
Toth ME, Gonda S, Vigh L, Santha M (2010) Neuroprotective effect of small heat shock protein, Hsp27, after acute and chronic alcohol administration. Cell Stress Chaperones 15(6):807–817. https://doi.org/10.1007/s12192-010-0188-8
Tunbridge EM, Huber A, Farrell SM, Stumpenhorst K, Harrison PJ, Walton ME (2013) The role of cateho-o-methyltransferase in reward processing and addiction. CNS Neurol Disord Drug Targets 11:306–323
Wada K (2011) The history and current state of drug abuse in Japan. Ann N Y Acad Sci 1216(1):62–72. https://doi.org/10.1111/j.1749-6632.2010.05914.x
Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ, Westley J (1980) Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 181(1):151–160. https://doi.org/10.1016/0006-8993(80)91265-2
Wiechelman KJ, Braun RD, Fitpatrick JD (1988) Investigation of the bicinchoninic acid protein assay: identification of the groups responsible for color formation. Anal Biochem 175(1):231–237. https://doi.org/10.1016/0003-2697(88)90383-1
Yamamoto BK, Zhu W (1998) The effects of methamphetamine on the production of free radicals and oxidative stress. J Pharmacol Exp Ther 287(1):107–114
Yang LZ, Tovote P, Rayner M, Kockskämper J, Pieske B, Spiess J (2010) Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart. Eur J Pharmacol 632(1-3):1–6. https://doi.org/10.1016/j.ejphar.2010.01.027
Yu Y, Wei SG, Zhang ZH, Weiss RM, Felder RB (2016) ERK1/2 MAPK signaling in hypothalamic paraventricular nucleus contributes to sympathetic excitation in rats with heart failure after myocardial infarction. Am J Physiol Heart Circ Physiol 310(6):H732–H739. https://doi.org/10.1152/ajpheart.00703.2015
Acknowledgements
The authors want to thank Dr. Julie Howarth and Ms. Ashleigh Thompson for her assistance with cardiac histopathology.
Funding
Funding for this study was provided by a Royal Society grant (RG120556; P.I. Alexis Bailey). The sponsors had no involvement in the design of the study and in the collection, analyses, and interpretation of the data nor in the writing of the manuscript and the decision to submit this article for publication.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All experimental procedures were conducted in accordance with the UK Animal Scientific Procedures Act (1986).
Rights and permissions
About this article
Cite this article
García-Carmona, J.A., Georgiou, P., Zanos, P. et al. Methamphetamine withdrawal induces activation of CRF neurons in the brain stress system in parallel with an increased activity of cardiac sympathetic pathways. Naunyn-Schmiedeberg's Arch Pharmacol 391, 423–434 (2018). https://doi.org/10.1007/s00210-018-1470-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-018-1470-z